Notes to the accounts

6. Taxation

 

Continuing

Year ended
31 July 2009
£m

Continuing
Year ended
31 July 2008
£m

Discontinued

Year ended
31 July 2009
£m

Discontinued
Year ended
31 July 2008
£m

The taxation charge for the year comprises

 

 

 

 

– current taxation

65.7

67.0

 

 

– deferred taxation

29.2

8.0

0.2

2.3

Total taxation expense in the income statement

94.9

75.0

0.2

2.3

Current taxation

 

 

 

 

– UK corporation tax

 

 

 

 

– foreign tax

65.7

67.0

 

 

– discontinued tax

 

 

 

 

 

65.7

67.0

 

 

 

Reconciliation of the total tax charge

The tax expense on the profit for the period is different from the standard rate of corporation tax in the UK of 28% (2008: 29.3%). The difference is reconciled as follows:

 

Continuing

Year ended
31 July 2009
£m

Continuing
Year ended
31 July 2008
£m

Discontinued

Year ended
31 July 2009
£m

Discontinued
Year ended
31 July 2008
£m

Profit before tax

370.8

319.3

(5.7)

26.8

Notional taxation expense at UK rate of 28% (2008: 29.3%)

103.8

93.7

(1.6)

7.9

Effect of overseas taxation

10.6

8.2

 

 

Compliance benefits

(16.8)

(12.4)

 

 

Local incentives

(8.8)

(16.1)

 

 

Tax effect of other non-headline items

6.1

1.6

 

 

Tax effect of Aerospace sale

 

 

1.8

(5.6)

 

94.9

75.0

0.2

2.3

Comprising

 

 

 

 

– taxation on headline profit

88.8

91.3

 

 

– tax on non-headline profit/(loss)

6.1

(16.3)

 

 

– tax on sale of discontinued operations

 

 

0.2

2.3

Total taxation expense in the income statement

94.9

75.0

0.2

2.3

 

 

Year ended
31 July 2009
£m

Year ended
31 July 2008
£m

Tax on items charged/(credited) to equity

 

 

Current tax credit

 

 

– share-based payment

 

(5.2)

 

 

(5.2)

Deferred tax (credit)/charge

 

 

– retirement benefit schemes

(94.3)

(75.5)

– share-based payment

4.0

3.8

 

(90.3)

(76.9)

 

Deferred taxation

 

Excess tax
depreciation
on fixed assets
and goodwill
£m

Share-based
payment
£m

Retirement
benefit
obligations
£m

Capitalised
development
expenditure
£m

Other
£m

Total
£m

At 31 July 2007

(72.1)

15.7

(55.2)

(10.2)

97.8

(24.0)

Credit/(charge) to income statement

9.7

0.3

(31.3)

(1.6)

12.6

(10.3)

Charge to equity

 

(3.8)

75.5

 

 

71.7

Other

 

 

 

 

6.0

6.0

Disposals

 

 

 

 

(12.8)

(12.8)

Exchange adjustments

(1.9)

 

0.5

(0.2)

2.9

1.3

At 31 July 2008

(64.3)

12.2

(10.5)

(12.0)

106.5

31.9

Deferred tax assets

(2.6)

0.3

19.7

(4.6)

83.4

96.2

Deferred tax liabilities

(61.7)

11.9

(30.2)

(7.4)

23.1

(64.3)

At 31 July 2008

(64.3)

12.2

(10.5)

(12.0)

106.5

31.9

Credit/(charge) to income statement

8.0

(4.3)

(35.8)

(4.0)

6.7

(29.4)

Charge to equity

 

(4.0)

94.3

 

 

90.3

Other

(4.1)

 

 

 

 

(4.1)

Exchange adjustments

(8.0)

 

3.0

(1.6)

16.1

9.5

At 31 July 2009

(68.4)

3.9

51.0

(17.6)

129.3

98.2

Deferred tax assets

(4.9)

3.9

50.6

(8.9)

124.0

164.7

Deferred tax liabilities

(63.5)

 

0.4

(8.7)

5.3

(66.5)

At 31 July 2009

(68.4)

3.9

51.0

(17.6)

129.3

98.2

 

Included in Other above is a deferred tax liability of £4.0m (2008: £9.3m) relating to unremitted overseas earnings. No additional tax liabilities have been recognised because the Group is in a position to control the timing of other temporary differences and it is probable that such differences will not reverse in the future. Other deferred tax also includes the tax benefits of losses carried forward amounting to £31.3m (2008: £26.7m).

The Group has not recognised deferred tax assets relating to tax losses of £78.3m (2008: £102.2m), due to uncertainty as to their recoverability. The expiry date of operating losses carried forward is dependent upon the law of the various territories in which the losses arise. A summary of expiry dates for losses in respect of which restrictions apply is set out below.

Restricted losses

 

2009
£m

Expiry of
losses

2008
£m

Expiry of
losses

Territory

 

 

 

 

– Americas

10.7

2019-2025

10.7

2019-2025

Total restricted losses

10.7

 

10.7

 

Unrestricted losses:

 

 

 

 

– operating losses

67.6

No expiry

91.5

No expiry

Total

78.3

 

102.2

 



Smiths Group divisions:
Smiths Detection, Smiths Medical, John Crane, Smiths Interconnect, Flex-Tek

 

Smiths Group plc:
Registered office 2nd Floor, Cardinal Place, 80 Victoria Street, London SW1E 5JL, UK
Incorporated in England No. 137013
Copyright 2009 Smiths Group plc.
All rights Reserved | Legal Notice | Privacy Policy